CIK: 0001990716
Total reported value
$135.6M
Reporting period: 2026-03-31 · Number of holdings: 3
TRV GP VI, LLC disclosed 3 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $135.6M and a quarterly turnover rate of 13.7%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "T"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Trim SEPN
0.0% -$16.2M
Add RAPP
0.0% $920.8K
Add TNGX
0.0% $2.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SEPN | Septerna INC | Stock-Other | 74.64% | -4.41% | — | |
| 2 | RAPP | Rapport Therapeutics INC | Stock-Other | 22.37% | +2.57% | — | |
| 3 | TNGX | Tango Therapeutics INC | Stock-Other | 3.00% | +1.84% | — |
Performance for Q3 2026
+40.6%
Performance Last 4 Quarters
+169.1%
Based on 75% of reported portfolio value with available pricing
Not enough sector-mapped data yet
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RAPP | Rapport Therapeutics INC | +2.6% | — | Unchanged |
| 2 | TNGX | Tango Therapeutics INC | +1.8% | — | Unchanged |
| 3 | SEPN | Septerna INC | -4.4% | — | Unchanged |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-07 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-13 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-13 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-08 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-09 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-13 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0002087873
Total reported value
$135.6M
85 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001512538
Total reported value
$135.6M
77 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001777734
Total reported value
$135.6M
4 stks
2026-03-31
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0001990717
Total reported value
$401.0M
3 stks
2026-03-31
2 of the top 5 holdings overlap, including Rapport Therapeutics INC
CIK 0000200406
Total reported value
$652.4M
16 stks
2026-03-31
1 of the top 5 holdings overlap, including Rapport Therapeutics INC
CIK 0001274403
Total reported value
$677.1M
10 stks
2026-03-31
1 of the top 5 holdings overlap, including Rapport Therapeutics INC